°¢Ë¾Æ¥ÁÖÀµ°±ËáÑÎ,aspirin-DL-lysineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ù¿ÆÊÖÊõ,PaediatricÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÉÈÅËØ-¦Ë2,IFN-¦Ë2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Æ¥¶àĪµÂ¿Ú·þÒº,PIDOTOMODÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ÙÐÔÈ©¹Ìͪ¼õÉÙÖ¢,pseudohypoaldosteronismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»¹¶û½ð,HuanerjinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÖÏÏ¢ºóѪÇå,postasphyxial-serumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔÙ¸ÉÔ¤,re-interventionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Î²¿Òô,raleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍÁ×ËáøѪ֢,hypophosphatasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃâÒßÖ²¡»úÖÆ,immunopathogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±ÇÈûÊ½ÆøµÀ³ÖÐøÕýÑ¹Í¨Æø,NCPAPÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö§ÔÌåIgM¿¹Ìå,Mp-IgMÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉú¶ùºôÎü¾½ÆÈ×ÛºÏÖ¢,NRDSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ÙÐÔ¼××´ÅÔÏÙ»úÄܼõÍËÖ¢,pseudohypoparathyroidism(PHP)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉú´óÊó,Neonatal RatÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾ªØÊ³ÖÐø×´Ì¬,Status convulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½Ç»¯Ï¸°ûÉú³¤Òò×Ó,keratinocyte growth factorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
IgGÑÇÐÍ,IgG subclassÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶àÔàÆ÷¹¦ÄÜÕϰ×ÛºÏÖ¢,Multiple organ dysfunction syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Î÷Ñó,the WestÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃâÒß·´Ó¦ÐÔÒȵºËØ,Immunoreactive insulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉúÓ¤¶ù,Newborn infantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔ¼²²¡/Õï¶Ï,Brain Diseases/DiagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µçѹÃſؼØÀë×ÓͨµÀ,voltage-gated potassium channelsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼à²âÓë·ÖÎö,Surveillance and analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾ëÄPÎïÖÊ,Substance PÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÎæÈÈ×ÛºÏÕ÷,muggy syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õæ¾ú·ÎÑ×,fungus pneumoniaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á¼ÐÔ¼Ò×åÐÔÓ¤¶ù¾ªØÊ,Benign familial infantile convulsionsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Î£ÖØ²¡ÀýÆÀ·Ö,critical illness scoreÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³ÖÐø¾²ÂöµÎ×¢,Continuous infusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
С¶ù¾ªØÊ,Infantile convulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Î£ÖØ¶ù,Critically ill childrenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºôÎüµÀ×èÈû,airway obstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¡ËáÁ×Ëἤøͬ¹¤Ã¸,creatine kinase MBÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ì춬°±Ëá°±»ù×ªÒÆÃ¸Àà/·ÖÎö,Aspartate aminotransferases/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Î£ÖØ»¼¶ù,critical childrenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾²Âö×¢Éä±ûÖÖÇòµ°°×,intravenous immunoglobulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á¬ÐøÉöÌæ´úÖÎÁÆ,continuous renal replacement therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ø±ðÕï¶ÏÖ¸±ê,differential diagnostic indexesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉú¶ù¾ªØÊ,Neonatal seizuresÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È«ÃæÐÔñ²üê°éÈÈÐÔ¾ªØÊ¸½¼ÓÖ¢,generalized epilepsy with febrile seizures plusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍËÈÈÌù,cooling pasteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾ªØÊÐÔÄÔËðÉË,convulsion-induced brain injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßÉøÑªÖ¢,Plasma hyperosmolalityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹Ü»îÐÔÒ©,vasoactive drugÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éàϵηþ,dropping under tongueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ùͯ¸ßÈÈ,childnen high feverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ÉÈÜÐÔÖ×Áö»µËÀÒò×ÓÊÜÌå¢ñ,Soluble tumor necrosis factor receptor-¢ñÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊîÈÈÖ¢,summer feverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶îÒ¶ÄÔ»Ø,Frontal lobe gyrusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±»¶¯Ä¤ÌØÐÔ,passive membrane propertiesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢Á¿ÑªÌÇ,microamount Blood GlucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
С¶ùÎ£ÖØ²¡ÀýÆÀ·Ö,The pediatric critical illness scoringÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈȾªØÊ,febrile convulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ÙÑ×Ö¢/¿¹Ñ×Ö¢,Pro-inflammatory / Anti-inflammatoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µçѹÃÅ¿ØÄÆÍ¨µÀ¦Â1Ñǵ¥Î»,voltage-gated sodium channel ¦Â1 subunitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆøµÀÎü³öÎï,tracheal aspiratesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×ÐÍH1N1Á÷¸ÐÎ£ÖØÖ¢,severe influenza A(H1N1)virus infectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ÒÍ¥Ô¤·À,family preventionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ù¿ÆÎ£ÖØÖ¢,pediatric intensive caseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ð¡¸Æµ°°×-I,cardial troponin IÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦Ëðº¦,gastrointestinal damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θ³¦Î¹Ñø,gastrointestinal feedingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·´¸´¸ßÈȾªØÊ,recurrent febrile seizuresÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ŧ¶¾Ö¢×ÛºÏÕ÷/øѧ,Sepsis Syndrome/enzymologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·¢Óý³Ù»º,developmental delayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ùÍ¯ÖØÖ¢¼à»¤²¡·¿,Pediatric intensive care unit(PICU)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÀÁÖ»ìÐüÒº,high feverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßÌǸßÉøÑªÖ¢,Hyperglycemic hyperosmolarityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿É¿Ø¹ÄÅÝʽÕýѹºôÎüÖ§³Ö×°ÖÃ,Bubble positive pressure breathing deviceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ȱÑõȱѪÐÔÄÔËðÉË,hypoxic-ischemic brain damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÏÖªÉñ¾¿ÆÑ§,cognitive neuroscienceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ì¥·àÎüÈë×ÛºÏÕ÷,meconium aspiration syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉú¶ùÆÆÉË·ç,Neonatal tetanusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÂÕæÑµÁ·,simulation trainingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¨ºìËØÄÔ²¡,Bilirubin encephalopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¿Ñõ,pure oxygenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈË¿ÚÖÊÁ¿,Population qualityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±½±û°±ËáôÇ»¯Ã¸,phenylalanine hydroxylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ì¥·àÎüÈë,meconium aspirationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ôç²ú¶ùÊÓÍøÄ¤²¡,Retinopathy of prematurityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³±ÆøºôÎü,tidal breathingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ìý¾õ,auditoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʧƥÅ为²¨,mismatch negativityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔѪÁ÷ËÙ¶È,cerebral blood flow velocityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÜÀíÄ£¿é,management moduleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉú¶ùȱÑõȱѪÐÔÄÔ²¡,Hypoxic-ischemic encephalopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËѪÇåµ°°×,human serum albuminÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ª°²ÊÐ,Ji an CityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÈÌìÐÔ¼××´ÏÙ¹¦ÄܼõÍËÖ¢,Congenital hypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò»Ñõ»¯µª/ѪҺ,Nitric oxide/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒõÀë×Ó¼ä϶,Anion gapÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÈÌìÐÔ¼××´ÏÙ¹¦ÄܵÍÏÂ,congenital hypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ßƵÕñµ´,high frequency oscillationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾±£»¤¼Á,neuroprotective agentsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Î±íÃæ»îÐÔ¼Á,Pulmonary surfactantsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÔËðÉË/ÖÎÁÆ,brain injuries/THÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎÑ××ÛºÏÕ÷,hepatitis syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|